The antibody contained in this product is an immunoglobulin M (IgM) monoclonal antibody, which is specifically produced against the laminin receptor on tumor cells. The antibody is bound to the surface of the liposome coated with doxorubicin through a disulfide bond and has the potential to selectively target tumor cells.
The combination of targeted antibody-mediated delivery and the cytotoxic effects of doxorubicin presents a promising therapeutic strategy. This approach not only aims to improve the efficacy of cancer treatment by ensuring that the drug is delivered directly to the tumor cells but also minimizes side effects commonly associated with conventional chemotherapy. By leveraging the unique properties of IgM antibodies and liposomal technology, this product holds significant potential in enhancing cancer treatment outcomes and advancing personalized medicine.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-862 | Recombinant Anti-human RPSA Antibody | ELISA, IP, FuncS | IgG |
MOB-1797MZ | Recombinant Mouse Anti-Human RPSA Antibody | WB | Mouse antibody |
HPAB-0126-WJ | Mouse Anti-RPSA Recombinant Antibody (clone ESM-16) | ELISA | Mouse IgG1 |
HPAB-0132-WJ | Mouse Anti-RPSA Recombinant Antibody (clone BV-27) | ELISA, WB, FC | Mouse IgG2a |
VS-0923-FY209 | Recombinant Mouse Anti-RPSA Antibody (VS-0923-FY209) | ELISA, WB | Mouse IgG2a |
There are currently no Customer reviews or questions for VS-1024-FY2. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.